择期腹部大手术患者个体化围术期血压管理:IMPROVE-multi随机临床试验
这项在15家德国大学医院开展的随机单盲临床试验纳入45岁及以上、接受预计90分钟以上全麻择期腹部大手术且至少具有1项额外高危标准的患者(2023年2月26日至2024年4月25日入组,末次随访2024年7月25日)。患者1:1随机接受个体化围术期血压管理(MAP目标基于术前夜间平均MAP)或常规血压管理(MAP目标65 mmHg或以上)。主要终点为术后7天内急性肾损伤、急性心肌损伤、非致命性心脏骤停或死亡的复合结局。结果显示个体化组主要终点发生率为33.5%(190/567),常规组为30.5%(173/567),相对风险1.10(95%CI 0.93-1.30,P=.31),无显著差异;22项次要终点也均无显著差异。
要点
- 高危择期腹部大手术患者中,个体化血压管理组主要复合终点发生率33.5%(190/567),常规组30.5%(173/567),相对风险1.10(95%CI 0.93-1.30,P=.31)。
- 术后7天内感染并发症个体化组15.9%(90/567) vs 常规组17.1%(97/567),P=.63,无显著差异。
- 术后90天内肾脏替代治疗、心肌梗死、非致命性心脏骤停或死亡复合结局个体化组5.7%(32/566) vs 常规组3.5%(20/567),P=.12,无显著差异。
- 共纳入1134例进行主要分析,中位年龄66岁(IQR 59-73岁),女性占34.1%。
- 22项次要结局均无显著差异。
适用人群与场景
- 45岁及以上、接受预计90分钟以上全麻择期腹部大手术、且至少具有1项额外高危标准的患者。
处置流程与药物剂量
- 个体化围术期血压管理:MAP目标基于术前使用自动血压监测评估的平均夜间MAP。
- 常规血压管理:MAP目标为65 mmHg或以上。
研究设计与关键结果
- 研究类型:随机单盲临床试验,15家德国大学医院,2023年2月26日至2024年4月25日入组,末次随访2024年7月25日。
- 入组1272例,随机1142例(每组571例),主要分析纳入1134例(中位年龄66岁,IQR 59-73岁;女性34.1%)。
- 主要终点(术后7天内急性肾损伤、急性心肌损伤、非致命性心脏骤停或死亡的复合结局):个体化组190/567(33.5%) vs 常规组173/567(30.5%),相对风险1.10(95%CI 0.93-1.30),P=.31。
- 术后7天内感染并发症:个体化组90/567(15.9%) vs 常规组97/567(17.1%),P=.63。
- 术后90天内肾脏替代治疗、心肌梗死、非致命性心脏骤停或死亡复合结局:个体化组32/566(5.7%) vs 常规组20/567(3.5%),P=.12。
- 22项次要结局均无显著差异。
证据类型、等级与局限
- 证据类型:随机单盲临床试验(RCT)。
- 试验注册号:ClinicalTrials.gov NCT05416944。
- 局限:原文未报告局限性。
对床旁实践的改变
- 在高危择期腹部大手术患者中,基于术前夜间平均MAP的个体化围术期血压管理与MAP目标65 mmHg或以上的常规管理相比,未降低术后7天内急性肾损伤、急性心肌损伤、非致命性心脏骤停或死亡的复合结局。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
IMPORTANCE: Intraoperative hypotension is associated with organ injury. However, it remains unknown if targeted blood pressure management during surgery can improve clinical outcomes.
OBJECTIVE: To evaluate whether individualized vs routine perioperative blood pressure management during major abdominal surgery improves clinical outcomes in patients considered at high risk of postoperative complications.
DESIGN, SETTING, AND PARTICIPANTS: This randomized single-blind clinical trial enrolled patients 45 years or older undergoing elective major abdominal surgery with general anesthesia expected to last 90 minutes or longer who had at least 1 additional high-risk criterion between February 26, 2023, and April 25, 2024, at 15 German university hospitals. The date of last follow-up was July 25, 2024.
INTERVENTION: Patients were randomized in a 1:1 ratio to individualized perioperative blood pressure management (with mean arterial pressure [MAP] targets based on preoperative mean nighttime MAP assessed using automated blood pressure monitoring) or routine blood pressure management with a MAP target of 65 mm Hg or higher.
MAIN OUTCOMES AND MEASURES: The primary outcome was the incidence of a composite outcome of acute kidney injury, acute myocardial injury, nonfatal cardiac arrest, or death within the first 7 postoperative days. There were 22 secondary outcomes, including infectious complications within the first 7 postoperative days and a composite outcome of need for kidney replacement therapy, myocardial infarction, nonfatal cardiac arrest, or death within 90 days after surgery.
RESULTS: Of the 1272 patients enrolled, 1142 were randomized (571 patients to each group), and 1134 were included in the primary analysis (median age, 66 years [IQR, 59-73 years]; 34.1% female). The primary outcome occurred in 190 of 567 patients (33.5%) assigned to individualized blood pressure management and 173 of 567 patients (30.5%) assigned to routine blood pressure management (relative risk, 1.10 [95% CI, 0.93-1.30]; P = .31). None of the 22 secondary outcomes were significantly different, including infectious complications within the first 7 postoperative days (90/567 [15.9%] vs 97/567 [17.1%]; P = .63) and a composite outcome of need for kidney replacement therapy, myocardial infarction, nonfatal cardiac arrest, or death within 90 days after surgery (32/566 [5.7%] vs 20/567 [3.5%]; P = .12).
CONCLUSIONS AND RELEVANCE: Among patients at high risk of postoperative complications undergoing major abdominal surgery, individualized perioperative blood pressure management with MAP targets based on preoperative mean nighttime MAP did not decrease the composite outcome of acute kidney injury, acute myocardial injury, nonfatal cardiac arrest, or death within the first 7 postoperative days compared with routine blood pressure management with a MAP target of 65 mm Hg or higher.
TRIAL REGISTRATION: ClinicalTrials.gov Identifier: NCT05416944.
参考来源
- Saugel B, Meidert AS, Brunkhorst FM, et al. Individualized Perioperative Blood Pressure Management in Patients Undergoing Major Abdominal Surgery: The IMPROVE-multi Randomized Clinical Trial. JAMA. 2025. PMID: 41076588. doi:10.1001/jama.2025.17235
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。